<?xml version="1.0" encoding="UTF-8"?>
<p>As shown in 
 <xref rid="molecules-26-00959-t003" ref-type="table">Table 3</xref> and 
 <xref rid="molecules-26-00959-t004" ref-type="table">Table 4</xref>, both carvacrol and 
 <italic>L. pubescens</italic> EO could be promising candidates for the development of formulas to be used mainly for the treatment of intestinal diseases caused by 
 <italic>S. typhimurium</italic> and 
 <italic>S. sonnei</italic>. The essential oil contact with these pathogens results in microorganism deactivation and a formulation of carvacrol with tetracycline hydrochloride was previous successfully used for the treatment of local mouth bacterial infections and candidiasis [
 <xref rid="B8-molecules-26-00959" ref-type="bibr">8</xref>]. Further horizons could be established by the combinations of carvacrol or 
 <italic>L. pubescens</italic> EO with classic antibiotics for the treatment of enteric pathogens.
</p>
